Additionally, metformin's impact on mTOR signaling could improve energy metabolism in ME/CFS and LC by downregulating an overactive but underperforming protein, thereby alleviating symptoms. The gene discussed is MTOR; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.